The Role of the Galaninergic System in Modulating Stress-Related Responses in an Animal Model of Posttraumatic Stress Disorder

Biological Psychiatry

Volumn 65, Issue 5, 2009, Pages 383-391

  Kozlovsky, Nitsan ^a   Matar, Michael A ^a   Kaplan, Zeev ^a   Zohar, Joseph ^a   Cohen, Hagit ^a  

^a MINISTRY OF HEALTH   (Israel)

Author keywords

5HT 1A; animal model; anxiety; brain derived neurotrophic factor (BDNF); galaninergic system; neuropeptide; posttraumatic stress disorder; resilience

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; COUMARIN DERIVATIVE; GALANIN; GALNON; PLACEBO; SEROTONIN 1A RECEPTOR; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

AGONIST; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUDITORY STIMULATION; BIOLOGICAL MODEL; CONTROLLED STUDY; DENTATE GYRUS; FRONTAL CORTEX; HIPPOCAMPUS; HORMONE BLOOD LEVEL; MALE; MAZE TEST; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; STARTLE REFLEX;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; CORTICOSTERONE; COUMARINS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FRONTAL LOBE; GALANIN; HIPPOCAMPUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1A; RNA, MESSENGER; STRESS DISORDERS, POST-TRAUMATIC; STRESS, PSYCHOLOGICAL; UP-REGULATION;

EID: 59449103338     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2008.10.034     Document Type: Article

References (56)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. (1994), American Psychiatric Association, Washington, DC
2. Morgan III C.A., Wang S., Southwick S.M., Rasmusson A., Hazlett G., Hauger R.L., et al. Plasma neuropeptide-Y concentrations in humans exposed to military survival training. Biol Psychiatry 47 (2000) 902-909
3. Yehuda R., Brand S., and Yang R.K. Plasma neuropeptide Y concentrations in combat exposed veterans: Relationship to trauma exposure, recovery from PTSD, and coping. Biol Psychiatry 59 (2006) 660-663
4. Gentleman S.M., Falkai P., Bogerts B., Herrero M.T., Polak J.M., and Roberts G.W. Distribution of galanin-like immunoreactivity in the human brain. Brain Res 505 (1989) 311-315
5. Branchek T.A., Smith K.E., Gerald C., and Walker M.W. Galanin receptor subtypes. Trends Pharmacol Sci 21 (2000) 109-117
6. Floren A., Land T., and Langel U. Galanin receptor subtypes and ligand binding. Neuropeptides 34 (2000) 331-337
7. Holmes A., Kinney J.W., Wrenn C.C., Li Q., Yang R.J., Ma L., et al. Galanin GAL-R1 receptor null mutant mice display increased anxiety-like behavior specific to the elevated plus-maze. Neuropsychopharmacology 28 (2003) 1031-1044
8. Bartfai T., Hokfelt T., and Langel U. Galanin-a neuroendocrine peptide. Crit Rev Neurobiol 7 (1993) 229-274
9. Bing O., Moller C., Engel J.A., Soderpalm B., and Heilig M. Anxiolytic-like action of centrally administered galanin. Neurosci Lett 164 (1993) 17-20
10. Crawley J.N. Biological actions of galanin. Regul Pept 59 (1995) 1-16
11. Crawley J.N. The role of galanin in feeding behavior. Neuropeptides 33 (1999) 369-375
12. Holmes A., Heilig M., Rupniak N.M., Steckler T., and Griebel G. Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders. Trends Pharmacol Sci 24 (2003) 580-588
13. Holmes A., Yang R.J., and Crawley J.N. Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice. J Mol Neurosci 18 (2002) 151-165
14. Holmes P.V., Blanchard D.C., Blanchard R.J., Brady L.S., and Crawley J.N. Chronic social stress increases levels of preprogalanin mRNA in the rat locus coeruleus. Pharmacol Biochem Behav 50 (1995) 655-660
15. Rustay N.R., Wrenn C.C., Kinney J.W., Holmes A., Bailey K.R., Sullivan T.L., et al. Galanin impairs performance on learning and memory tasks: Findings from galanin transgenic and GAL-R1 knockout mice. Neuropeptides 39 (2005) 239-243
16. Swanson C.J., Blackburn T.P., Zhang X., Zheng K., Xu Z.Q., Hokfelt T., et al. Anxiolytic- and antidepressant-like profiles of the galanin-3 receptor (Gal3) antagonists SNAP 37889 and SNAP 398299. Proc Natl Acad Sci U S A 102 (2005) 17489-17494
17. Wiesenfeld-Hallin Z., Xu X.J., Crawley J.N., and Hokfelt T. Galanin and spinal nociceptive mechanisms: Recent results from transgenic and knock-out models. Neuropeptides 39 (2005) 207-210
18. Wrenn C.C., Kinney J.W., Marriott L.K., Holmes A., Harris A.P., Saavedra M.C., et al. Learning and memory performance in mice lacking the GAL-R1 subtype of galanin receptor. Eur J Neurosci 19 (2004) 1384-1396
19. Barrera G., Echevarria D.J., Poulin J.F., Laforest S., Drolet G., and Morilak D.A. One for all or one for one: does co-transmission unify the concept of a brain galanin "system" or clarify any consistent role in anxiety?. Neuropeptides 39 (2005) 289-292
20. Moller C., Sommer W., Thorsell A., and Heilig M. Anxiogenic-like action of galanin after intra-amygdala administration in the rat. Neuropsychopharmacology 21 (1999) 507-512
21. Khoshbouei H., Cecchi M., Dove S., Javors M., and Morilak D.A. Behavioral reactivity to stress: amplification of stress-induced noradrenergic activation elicits a galanin-mediated anxiolytic effect in central amygdala. Pharmacol Biochem Behav 71 (2002) 407-417
22. Khoshbouei H., Cecchi M., and Morilak D.A. Modulatory effects of galanin in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress. Neuropsychopharmacology 27 (2002) 25-34
23. Morilak D.A., Cecchi M., and Khoshbouei H. Interactions of norepinephrine and galanin in the central amygdala and lateral bed nucleus of the stria terminalis modulate the behavioral response to acute stress. Life Sci 73 (2003) 715-726
24. Karlsson R.M., Holmes A., Heilig M., and Crawley J.N. Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice. Pharmacol Biochem Behav 80 (2005) 427-436
25. Ueyama T., Kawai Y., Nemoto K., Sekimoto M., Tone S., and Senba E. Immobilization stress reduced the expression of neurotrophins and their receptors in the rat brain. Neurosci Res 28 (1997) 103-110
26. Cohen H., Kaplan Z., Matar M.A., Loewenthal U., Zohar J., and Richter-Levin G. Long-lasting behavioral effects of juvenile trauma in an animal model of PTSD associated with a failure of the autonomic nervous system to recover. Eur Neuropsychopharmacol 17 (2008) 464-477
27. Kozlovsky N., Matar M.A., Kaplan Z., Kotler M., Zohar J., and Cohen H. Long-term down-regulation of BDNF mRNA in rat hippocampal CA1 subregion correlates with PTSD-like behavioural stress response. Int J Neuropsychopharmacol 10 (2007) 748-751
28. Rajarao S.J., Platt B., Sukoff S.J., Lin Q., Bender C.N., Nieuwenhuijsen B.W., et al. Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon. Neuropeptides 41 (2007) 307-320
29. Smith M.A., Makino S., Kvetnansky R., and Post R.M. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci 15 (1995) 1768-1777
30. O'Neal H.A., Van Hoomissen J.D., Holmes P.V., and Dishman R.K. Prepro-galanin messenger RNA levels are increased in rat locus coeruleus after treadmill exercise training. Neurosci Lett 299 (2001) 69-72
31. Palkovits M. Stress-induced expression of co-localized neuropeptides in hypothalamic and amygdaloid neurons. Eur J Pharmacol 405 (2000) 161-166
32. Sweerts B.W., Jarrott B., and Lawrence A.J. Expression of preprogalanin mRNA following acute and chronic restraint stress in brains of normotensive and hypertensive rats. Brain Res Mol Brain Res 69 (1999) 113-123
33. Sweerts B.W., Jarrott B., and Lawrence A.J. Acute and chronic restraint stress: effects on [125I]-galanin binding in normotensive and hypertensive rat brain. Brain Res 873 (2000) 318-329
34. Hokfelt T., Wiesenfeld-Hallin Z., Villar M., and Melander T. Increase of galanin-like immunoreactivity in rat dorsal root ganglion cells after peripheral axotomy. Neurosci Lett 83 (1987) 217-220
35. Holmes P.V., and Crawley J.N. Olfactory bulbectomy increases prepro-galanin mRNA levels in the rat locus coeruleus. Brain Res Mol Brain Res 36 (1996) 184-188
36. Villar M.J., Cortes R., Theodorsson E., Wiesenfeld-Hallin Z., Schalling M., Fahrenkrug J., et al. Neuropeptide expression in rat dorsal root ganglion cells and spinal cord after peripheral nerve injury with special reference to galanin. Neuroscience 33 (1989) 587-604
37. Austin M.C., Cottingham S.L., Paul S.M., and Crawley J.N. Tyrosine hydroxylase and galanin mRNA levels in locus coeruleus neurons are increased following reserpine administration. Synapse 6 (1990) 351-357
38. Cortes R., Villar M.J., Verhofstad A., and Hokfelt T. Effects of central nervous system lesions on the expression of galanin: a comparative in situ hybridization and immunohistochemical study. Proc Natl Acad Sci U S A 87 (1990) 7742-7746
39. Elliott-Hunt C.R., Marsh B., Bacon A., Pope R., Vanderplank P., and Wynick D. Galanin acts as a neuroprotective factor to the hippocampus. Proc Natl Acad Sci U S A 101 (2004) 5105-5110
40. Cortes R., Ceccatelli S., Schalling M., and Hokfelt T. Differential effects of intracerebroventricular colchicine administration on the expression of mRNAs for neuropeptides and neurotransmitter enzymes, with special emphasis on galanin: an in situ hybridization study. Synapse 6 (1990) 369-391
41. Theodorsson A., Holm L., and Theodorsson E. Hypothermia-induced increase in galanin concentrations and ischemic neuroprotection in the rat brain. Neuropeptides 42 (2008) 79-87
42. Saar K., Mazarati A.M., Mahlapuu R., Hallnemo G., Soomets U., Kilk K., et al. Anticonvulsant activity of a nonpeptide galanin receptor agonist. Proc Natl Acad Sci U S A 99 (2002) 7136-7141
43. Picciotto M.R., Hawes J.J., Brunzell D.H., and Zachariou V. Galanin can attenuate opiate reinforcement and withdrawal. Neuropeptides 39 (2005) 313-315
44. Zachariou V., Brunzell D.H., Hawes J., Stedman D.R., Bartfai T., Steiner R.A., et al. The neuropeptide galanin modulates behavioral and neurochemical signs of opiate withdrawal. Proc Natl Acad Sci U S A 100 (2003) 9028-9033
45. Badie-Mahdavi H., Behrens M.M., Rebek J., and Bartfai T. Effect of galnon on induction of long-term potentiation in dentate gyrus of C57BL/6 mice. Neuropeptides 39 (2005) 249-251
46. Lu X., Barr A.M., Kinney J.W., Sanna P., Conti B., Behrens M.M., et al. A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus. Proc Natl Acad Sci U S A 102 (2005) 874-879
47. Wu W.P., Hao J.X., Lundstrom L., Wiesenfeld-Hallin Z., Langel U., Bartfai T., et al. Systemic galnon, a low-molecular weight galanin receptor agonist, reduces heat hyperalgesia in rats with nerve injury. Eur J Pharmacol 482 (2003) 133-137
48. Adamec R., Bartoszyk G.D., and Burton P. Effects of systemic injections of vilazodone, a selective serotonin reuptake inhibitor and serotonin 1A receptor agonist, on anxiety induced by predator stress in rats. Eur J Pharmacol 504 (2004) 65-77
49. Adamec R., Holmes A., and Blundell J. Vulnerability to lasting anxiogenic effects of brief exposure to predator stimuli: Sex, serotonin and other factors-Relevance to PTSD. Neurosci Biobehav Rev 32 (2008) 1287-1292
50. Kinney J.W., Starosta G., and Crawley J.N. Central galanin administration blocks consolidation of spatial learning. Neurobiol Learn Mem 80 (2003) 42-54
51. Cohen H., Zohar J., Gidron Y., Matar M.A., Belkind D., Loewenthal U., et al. Blunted HPA axis response to stress influences susceptibility to posttraumatic stress response in rats. Biol Psychiatry 59 (2006) 1208-1218
52. Andreis P.G., Malendowicz L.K., Rebuffat P., Spinazzi R., Ziolkowska A., and Nussdorfer G.G. Galanin enhances corticosterone secretion from dispersed rat adrenocortical cells through the activation of GAL-R1 and GAL-R2 receptors coupled to the adenylate cyclase-dependent signaling cascade. Int J Mol Med 19 (2007) 149-155
53. Hohmann J.G., Krasnow S.M., Teklemichael D.N., Clifton D.K., Wynick D., and Steiner R.A. Neuroendocrine profiles in galanin-overexpressing and knockout mice. Neuroendocrinology 77 (2003) 354-366
54. Lyudyno V.I., Abdurasulova I.N., and Klimenko V.M. The role of the neuropeptide galanin in forming type-specific behavioral characteristics. Neurosci Behav Physiol 38 (2008) 93-98
55. Malendowicz L.K., Nussdorfer G.G., Nowak K.W., and Mazzocchi G. The possible involvement of galanin in the modulation of the function of rat pituitary-adrenocortical axis under basal and stressful conditions. Endocr Res 20 (1994) 307-317
56. Mazzocchi G., Rebuffat P., Gottardo G., Malendowicz L.K., and Nussdorfer G.G. Galanin stimulates glucocorticoid secretion in rats through a receptor-dependent activation of the adenylate cyclase/protein kinase A-dependent signaling pathway. Peptides 19 (1998) 891-895